| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/09/2008 | EP1908780A1 Novel chimeric proteins and methods for using the same |
| 04/09/2008 | EP1907418A2 Heterodimeric four helix bundle cytokines |
| 04/09/2008 | EP1394261A4 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 04/09/2008 | EP1360311B1 Membrane penetrating peptides and uses thereof |
| 04/09/2008 | CN101160322A Molecules and chimeric molecules thereof |
| 04/09/2008 | CN101157730A Fusion protein penetrating blood-brain barrier with nerve nourishment gene and encoding gene and uses thereof |
| 04/09/2008 | CN101157729A Tumour putrescence gene related apoptosis ligand variant and uses thereof |
| 04/09/2008 | CN101157728A ERK2 combination polypeptide and preparation thereof |
| 04/09/2008 | CN100379762C Interfusion protein between human serum albumin and interleukin, and encoding genes |
| 04/09/2008 | CN100379759C Compounds for treatment of infectious and immune system disorders and method for their use |
| 04/08/2008 | US7355025 Marker molecules associated with lung tumors |
| 04/08/2008 | US7355019 Cysteine-containing peptide tag for site-specific conjugation of proteins |
| 04/08/2008 | US7355017 Fusion polypeptide for use in the treatment and prevention of graft rejection |
| 04/08/2008 | US7355016 Methods for detection of mycobacteria |
| 04/08/2008 | US7354995 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for producing the complex structure |
| 04/08/2008 | US7354737 peptide delivers biological response modifiers into cytoplasm, intracellular organelles or nucleus of prokaryotic/eukaryotic cells; use in drug delivery, vaccines, gene and protein therapy |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
| 04/08/2008 | CA2253838C Dp and e2f protein nuclear localisation signals and their use |
| 04/08/2008 | CA2122732C Multivalent antigen-binding proteins |
| 04/03/2008 | WO2008038990A1 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 04/03/2008 | WO2008037080A1 Methods and compositions for immune response modulation and uses thereof |
| 04/03/2008 | WO2007131092A3 Chimeric t cell receptors and related materials and methods of use |
| 04/03/2008 | US20080081361 Process for production of a recombinant protein and a fusion protein |
| 04/03/2008 | US20080081355 Activatable recombinant neurotoxins |
| 04/03/2008 | CA2664529A1 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 04/02/2008 | EP1905832A2 Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 04/02/2008 | EP1905830A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/02/2008 | EP1905782A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 04/02/2008 | EP1244466B1 ACTIVATION OF THE IMMUNE SYSTEM BY AN NF-kappaB INDUCER AND AN ANTIGEN |
| 04/02/2008 | EP0815245B1 Bioactive il-12 fusion proteins |
| 04/02/2008 | CN101155916A Targeted plasminogen activator fusion proteins as thrombolytic agents |
| 04/02/2008 | CN101153268A High-efficiency method for producing regrouped human proinsulin C peptide series protein |
| 04/02/2008 | CN101153060A Amalgamation protein for estimating HCV NS3/4A serine protease inhibitor and uses thereof |
| 04/02/2008 | CN101153059A ELISA reagent kit for screening, diagnosis and treatment effect forecast of nasopharyngeal carcinoma |
| 04/02/2008 | CN101153054A Peptide for treatment of vascellum generation and uses thereof |
| 04/02/2008 | CN100378123C Chimeric chains that code for proteins that induce effects directed against viruses |
| 04/01/2008 | US7351803 CD16A binding proteins and use for the treatment of immune disorders |
| 04/01/2008 | US7351555 Expression vector comprising nucleotide sequences coding cytokine receptor (Zcytor16) for use as antagonist tool of interleukin-10 related t-cell derived inducible factor in diagnosis, treatment and prevention of cell proliferative and inflammatory disorders |
| 04/01/2008 | US7351409 Tumor antigens and CTL clones isolated by a novel procedure |
| 04/01/2008 | CA2341240C Autoantibody inhibitors |
| 03/27/2008 | WO2008034161A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses therefor |
| 03/27/2008 | WO2008000516A3 IMPROVED sgp130Fc DIMERS |
| 03/27/2008 | WO2007147527A3 Apiase protein construct |
| 03/27/2008 | WO2003075845A3 Immunogenicity of glucan binding protein |
| 03/27/2008 | US20080075739 Attenuated Salmonella SP12 Mutants as Antigen Carriers |
| 03/27/2008 | US20080075738 synthetic polypeptide biodrugs for treating viral disease; envelope protein, antigens, consisting of amino acid sequances from virus, more potent, protecting from T helper and B cell immunity |
| 03/27/2008 | US20080075659 Determining the percentage of monoclonal, chimerized, murine or humanized antibody greater than 90 percent using excess amount of CD66 antigen, and the percentage of immunoreactive antibody that binds specifically to CD66 |
| 03/27/2008 | CA2663545A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof |
| 03/26/2008 | EP1903113A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 03/26/2008 | EP1458866B1 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 03/26/2008 | CN101151280A Immunogenic molecules |
| 03/26/2008 | CN101148662A Heterogenous expression and purifying method for human AIDS virus auxiliary receptor CCR5 |
| 03/26/2008 | CN101148661A Human papilloma virus 16 type coat protein virus-like particles, preparation method and use thereof |
| 03/26/2008 | CN101148479A Recombination human collagen and biological synthesis method thereof |
| 03/26/2008 | CN101148478A Streptavidin-tumour putrescence factor alpha fusion protein |
| 03/26/2008 | CN101148477A Streptavidin-interleukins 2 fusion protein |
| 03/26/2008 | CN101148476A Inflammation related disease target treatment fusion protein |
| 03/26/2008 | CN101148475A Human breast cancer resisting recombination immunotoxin M4G3/ScFv-PE40 |
| 03/26/2008 | CN100376680C Dual target effected chimera recombinant, its construction method and application |
| 03/26/2008 | CN100376599C Recombining single chained three specific antibodies of anti CCA, anti CD 3, anti CD 28 through genetic engineering |
| 03/25/2008 | US7348408 Membrane protein fusion for use as diagnostic tool in genetic engineering; reporter gene expression |
| 03/25/2008 | US7348313 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 03/25/2008 | US7348162 Nucleotide sequences coding polypeptides for use in the treatment and prevention of hematopoietic disorders, osteoporosis, osteogenesis, paget's disease, periodontal disease, hypercalcemia, cancer, cachexia, and |
| 03/20/2008 | WO2008032874A1 Method for screening for agent capable of controlling in vivo hypoxia-responsive system |
| 03/20/2008 | WO2008032777A1 Antibacterial peptide and use thereof |
| 03/20/2008 | WO2008032659A1 Secretion signal peptide having improved efficiency, and method for production of protein by using the same |
| 03/20/2008 | WO2008031842A1 Inhibitors of gpr87 for cancer therapy |
| 03/20/2008 | WO2007140505A3 Vaccine carrier |
| 03/20/2008 | WO2004111075A3 Alternative reading frame polypeptides for treatment |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/19/2008 | EP1900816A2 GL50 molecules and uses therefor |
| 03/19/2008 | EP1900754A1 Fusion proteins comprising two lgG binding domains of streptococcal protein G |
| 03/19/2008 | EP1900377A1 Inhibitors of GPR87 for cancer therapy |
| 03/19/2008 | EP1700916B1 Novel centromeric protein shugoshin |
| 03/19/2008 | EP1009831B1 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 03/19/2008 | CN101146909A Antigen binding molecules directed to MCSP and having increased Fc receptor binding affinity and effector function |
| 03/19/2008 | CN101146827A HIV TAT-CD4 hybried molecules and methods of use thereof |
| 03/19/2008 | CN101146824A Means and methods for breaking noncovalent binding interactions between molecules |
| 03/19/2008 | CN101146823A Molecules and chimeric molecules thereof |
| 03/19/2008 | CN101144093A Recombination expression carrier and method for soluble expressing human I-type metallothionin |
| 03/19/2008 | CN101144080A Method for preparing recombination human VIP-Humanin fusion protein |
| 03/19/2008 | CN101143902A Anti-HER2 single-chain antibody-cefuroxime sodium enhanced fusion protein HER2(Fv-LDM) |
| 03/19/2008 | CN101143901A Application of fusion protein GST-PTD-SOD in radioresistance |
| 03/18/2008 | US7345145 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/18/2008 | CA2166102C Redirection of cellular immunity by receptor chimeras |
| 03/18/2008 | CA2015060C Novel antibody delivery system for biological response modifiers |
| 03/13/2008 | WO2008029921A1 Function-modified phenylalanine dehydrogenase, and method for analysis of amino acid in biological sample using the enzyme |
| 03/13/2008 | US20080064081 Reducing antigenicity of viral protein via amino acid sequence variation; enhancing vector transferability during gene therapy |
| 03/13/2008 | US20080063630 polynucleotides that code for polypeptides having activity for targeting heterogeneous polypeptides to the surfaces of cytoplasmic membranes, useful for analysis of proteind, delivery of cells expressing the polypeptide to a target site in vivo, preparation of an antibodies and vaccines, and gene therapy |
| 03/13/2008 | CA2663047A1 Therapeutic elastin-like polypeptide (elp) fusion proteins |
| 03/13/2008 | CA2662226A1 Fully human high yield production system for improved antibodies and proteins |
| 03/12/2008 | EP1896588A1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF |
| 03/12/2008 | EP1789440A4 Pancreatic polypeptide family motifs and polypeptides comprising the same |
| 03/12/2008 | EP1578791B1 Inclusion bodies for the oral vaccination of animals |
| 03/12/2008 | EP1506317B1 Marker molecules associated with lung tumors |
| 03/12/2008 | EP1278855B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/12/2008 | EP1210434B1 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 03/12/2008 | EP0876487B1 Mammalian cx3c chemokine genes |
| 03/12/2008 | CN101139613A Antineoplastic dibasic polypeptide and application and preparation method thereof |